#cardiovascular risk
Related Stories (2)
Novo says Ozempic shows lower risk of cardiovascular events compared to Lilly's Mounjaro - reuters.com
Novo says Ozempic shows lower risk of cardiovascular events compared to Lilly's Mounjaro reuters.com
September 29, 2026Novo Nordisk's anti-inflammatory drug fails to reduce cardiovascular risk in late-stage trial - Reuters
Novo Nordisk's anti-inflammatory drug fails to reduce cardiovascular risk in late-stage trial Reuters
July 31, 2026